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Abstract.  The present experiments were designed to 
clarify the relationship between cAMP elevation, 
proliferation and differentiation in Schwann cells. They 
were carried out on short-term cultures of cells ob- 
tained from neonatal rat sciatic nerves. 
It was found that the myelin-related phenotype was 
expressed in response to agents that elevate or mimic 
intraceUular cAMP (forskolin, cholera toxin,  cAMP 
analogues), provided, cell division was absent. This 
phenotype included upregulation of the major myelin 
protein Po and downregulation of GFAP,  N-CAM, 
A5E3,  and NGF receptor.  In contrast,  when cells 
were cultured in conditions where cell division oc- 
curred, elevation of intraceUular cAMP produced an 
alternative response, characterized by DNA synthesis 
and absence of myelin-related differentiation.  The 
cAMP mediated induction of an early Schwann cell 
antigen,  04,  followed a different pattern since it was 
induced equally in dividing and nondividing cells. 
These observations are consistent with the proposal 
that during development of the rat sciatic nerve:  (a) 
cAMP elevation, possibly induced by axon-associated 
factors, is a primary  signal responsible for the induc- 
tion of 04 expression in proliferating Schwann cells 
during the premyelination period; (b) subsequent with- 
drawal of cells associated with the larger axons from 
the cell cycle acts as a permissive secondary signal for 
induction of myelination,  since in quiescent cells the 
ongoing cAMP elevation will trigger myelination. 
T 
hE adenyl cyclase-cAMP second messenger pathway 
has been implicated  in the regulation  of growth  and 
development in several cell types, including  Schwann 
cells,  the major glial  element in peripheral  nerves.  Thus, 
cAMP elevation stimulates  DNA synthesis in Schwann cells 
cultured in the presence of serum or growth factors (9,  10, 
14, 40, 42, 43, 51). In cultured Schwann cells it also triggers 
the surface expression  of two lipids,  galactocerebroside and 
04 (sulfatide),  both of which are found on myelin-forming 
and non-myelin-forming Schwann cells in adult nerves (20, 
32,  50,  51). During  development  of the rat  sciatic  nerve, 
galactocerebroside appears at embryo day(E)  18-19 in cells 
destined to form myelin, and during the second to fifth post- 
natal  week in  non-myelin-forming  cells.  04 on the other 
hand is an early Schwann cell differentiation marker appear- 
ing at El6. The effect of cAMP on induction of the major my- 
elin glycoprotein  Po is more controversial.  Although  it has 
been reported that elevation of cAMP does not induce Po in 
short-term  cultured  Schwann  cells (49,  51),  other studies 
show that cAMP induces  expression of Po and also induces 
Po mRNA and  myelin  basic protein  mRNA in  long-term 
Schwann cell cultures that have previously been exposed to 
mitogenic stimulation  (24). 
These in vitro studies suggest that cAMP might be an in- 
tracellular  signal during several different stages of Schwann 
cell development.  In synergy with other factors,  it might 
drive Schwann  cel  ! proliferation  in  developing  nerves;  it 
could act as a signal triggering early Schwann cell differenti- 
ation,  i.e.,  04 appearance;  or it could be a signal  for the 
emergence of the myelin phenotype or for the final matura- 
tion of nonmyelin-forming  cells. 
The proposal that cAMP elevation is involved in regulation 
of these disparate events during  the in vivo development of 
the rat sciatic nerve raises at least three questions. First, does 
cAMP elevation unambiguously mimic myelin-related  dif- 
ferentiation  in rat Schwann cells? Second, if so, what is the 
timing mechanism  that in vivo would allow cAMP elevation 
to induce 04 at El6 (32) but myelin-related  differentiation, 
as exemplified by Po expression,  5-6 d later (around birth) 
(29.55).  Third,  is  induction  of the  myelin  phenotype by 
cAMP in cultured cells incompatible with stimulation of DNA 
synthesis, as predicted by the observation that in vivo myelin- 
related differentiation  does not occur in dividing  ceils (56). 
To answer these questions we have investigated the rela- 
tionship between induction of the myelin phenotype, induc- 
tion of 04 expression and stimulation of DNA synthesis. We 
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tures elevation of intracellular cAMP not only induces ex- 
pression of Po but, in the same cells, triggers downregula- 
tion  of  several  proteins  normally  downregulated  during 
myelination in vivo,  including GFAP, N-CAM, and ASE3, 
and also nerve growth factor (NGF) receptors (NGFR) ~  de- 
tected by the 217c antibody (8, 15, 18, 21, 23, 26, 27, 3t, 36). 
Significantly, we find that in short-term Schwann cell cul- 
tures, these changes only take place if the proliferative re- 
sponse to cAMP is prevented. In contrast, 04 expression is 
readily induced by cAMP in dividing cells. 
These observations, and earlier work on the regulation of 
galactocerebroside expression are consistent with the pro- 
posal that cAMP acts as a second messenger of an early and 
general Schwann cell differentiation signal. They also suggest 
that factors regulating Schwann cell proliferation control the 
transition from the premyelin to the myelin phenotype. 
Materials and Methods 
Schwann Cell Culture 
Sciatic nerves were dissected from early postnatal rats (5-7  d) and de- 
sheathed. 5-d rats were used in most experiments. The tissue was dissoci- 
ated essentially by the method of Brockes et al.  (4),  and maintained in 
DMEM  with added glutamine,  insulin,  and  10%  calf serum.  Cytosine 
arabinoside, 10  -5 M, was added after 24 h for 48 h to give cultures that 
were 95 % pure (4).  On the fourth day cells were plated on to coverslips 
coated with polylysine, polylysine plus laminin, or extracellular matrix as 
required, at a density of between 2.5-20,000 cells/coverslip. Cells were left 
for 24 h before further treatment. In most experiments, Schwann cells were 
cultured  on laminin but  in  some experiments, polylysine or coverslips 
coated with extracellular matrix from bovine corneal endothelial cells were 
used. Cells were cultured in defined medium consisting of a 1:1 mixture of 
DMEM and Ham's F12 medium supplemented with selenium (100/zg.ml-t), 
triiodothyronine (0.1 /zg.ml-l), transferrin (100  #g.ml-l), putrescine (16 
/~g.ml-t), thyroxine (0.4/~g.ml-t), progesterone (60 ~g-ml-t), 30% BSA 
(Path-o-cyte, ICN Immunologicals, Lisle, IL) (0.3 mg.ml-~), dexametha- 
sone (38  ng.ml-l),  insulin (5  #g.mi-l)  with or without the addition of 
NGF (10 U.mi-l), glucose (2 mg.ml-l), 10% calf serum or glial growth 
factor (GGF) at a concentration of 1.8 #g-ml  -t. The GGF was a semipure 
fraction (GGF-CM) prepared by Dr.  A. J. D. Goodearl (Ludwig Institute, 
London) as described elsewhere (47). Calf serum was added in concentra- 
tions ranging from zero to  10%. 
Cell Culture in the Presence of Cholera Toxin 
Cholera toxin (C'lx) (Sigma Chemical Co., St. Louis, MO) (150 ng.ml  -x) 
was added to Sehwann cell cultures for 1 h at the start of experiments, and 
24 hr later for an additional hour. In experiments lasting >4 d, CTx was 
added for 1 h at 96 and 168 h. As a control for the specificity of the CTx, 
the ~ subunit was used in some experiments at the same concentration and 
using a similar regime to that used for CTx. 
Cell Culture in the Presence of  Forskolin 
In some experiments forskolin, a reversible activator of adenyl cyclase was 
added to cells cultured in media as described above. A 10 mM stock in alco- 
hol was diluted in medium and added at concentrations varying from 0.01 
to 200 #M. At the higher concentrations a control containing alcohol alone 
was added to the experiment. The forskolin was replaced in new medium 
every 24 h. 
Cell Culture in the Presence of  cAMP Analogues 
In these experiments Schwann cells were placed 6n coverslips coated with 
1. Abbreviations used in this paper: BrdU, bromodeoxyuridine; CTx, chol- 
era toxin; GCF, glial growth factor; IBMX, 3-isobutyl-l-methylxanthine; 
NGFR, nerve growth factor receptor. 
polylysine, laminin, or extracellular matrix. They were cultured in media 
as described above,  cAMP analogues, NS,2'-O-dibutyryladenosine 3':5'- 
cyclic monophosphate (db-cAMP) (5  ×  10  -4 M) plus 8-bromoadenosine 
3':5'-cyclic monophosphate (8 bromo-cAMP) (5  ×  10  -4 M) were added at 
the start of the experiment. At 24 h and 48 h, fresh medium containing the 
two analogues, each at a concentration of 5  ×  10  -5 M, was added to the 
cultures. If experiments  lasted >3 d, this dose was repeated every day until 
the end of the experiment. Similar concentrations of butyrate were used in 
control experiments. 
Cell Culture in Isobutylmethylxanthine 
A 50 mM stock solution of  3-isobutyM-methyl-xanthine  (IBMX), an inhibi- 
tor of cAMP hydrolysis, (Sigma Chemical Co., St. Louis, MO) in 50% eth- 
anol was diluted 1:5 in PBS. This solution (10 mM in 10%  ethanol) was 
used to give a final dilution of 100 #M in Schwann cell cultures at the start 
of  the experiment. At 24 and 48 h, fresh medium containing 100 I~M IBMX 
was added to the cultures. Control cultures contained 0.1% ethanol. 
Substratum Coating 
13-mm-diam round glass coverslips were incubated with polylysine (1 
mg.mi  -t) at room temperature for 24 h, washed with six changes of sterile 
distilled water over a period of  4 d, and allowed to dry. Laminin-coated cov- 
erslips were prepared by incubating polylysine-coated  coverslips with 50 ~tl 
of laminin solution (Gibco Laboratories) (20 ng-mi  -l in DME) for 2 h be- 
fore plating with Schwann cells. Extracellular matrix coated coverslips were 
prepared from bovine endothelial cells as described previously (10) and 
stored in sterile PBS at 4°C until required for use. 
Antibodies 
Rabbit anti-Po was produced and characterized by Brockes et al. (5) and 
used at a dilution of 1:200. Rabbit anti-N-CAM was produced and charac- 
terized by Gennarini et al. (16) and used at a dilution of 1:500. Rabbit anti- 
GFAP  and  rabbit  anti-Sl00  (Dako  Immunoglobulins  A/s;  Dakopatts, 
Copenhagen, Denmark) were used at a dilution of 1:100 and 1:1,000, respec- 
tively.  Ascites fluid containing mouse mAb to galactocerebroside (IgG3), 
produced and characterized by Ranscht et al. (44) was used at a dilution 
of 1:200. Supernatant containing mouse mAb 04 (IgM) (52) was used at a 
dilution of 1:1. Ascites fluid containing mouse mAb ASE3 (IgG2a) (30) was 
used at a dilution of 1:500.  Ascites fluid to mouse mAb to Po (0.4)  pro- 
duced and characterized by Dr. C. Linington (Max Planck Institut fOr Psy- 
chiatric, Martinsreid, FRG) was used at a dilution of 1:500. Mouse mono- 
clonal anti-GFAP (clone G-A-5; Boehringer, Mannheim, FRG) was used at 
a dilution of 1:4.  Mouse mAb 217c supernatant (37), which has recently 
been shown to  recognize NGFR  (15),  was used at a  dilution of 1:500. 
Purified mouse  mAb  192-IgG  (1.3 mg/ml)  (53)  which also  recognizes 
NGFR was used at a  dilution of 1:1,000.  Mouse monoclonal anti-BrdU 
(Bu20a)  (IgG1) supernatant was used at a dilution of 1:20 (17). Fluorescein 
or tetramethyl rhodamine-conjugated to goat anti-rabbit Ig (G-antl-RIg-Fl 
or G-anti-RIg-Rd) (Cappel Laboratories, Ltd., Malvern, PA) absorbed with 
mouse Ig,  were used at  a  dilution of 1:300.  Fluorescein or tetramethyl 
rhodamine conjugated to goat anti-rabbit Ig (G-anti-MIg-F1 or G-anti-MIg- 
Rd) (Cappel Laboratories, Ltd.) absorbed with rabbit Ig, were used at a di- 
lution of 1:150. Biotinylated sheep anti-mouse Ig and streptavidin-Texas  Red 
(Amersham International, Amersham, UK) were both used at a dilution 
of 1:100. 
Immunofluorescence 
Antibodies were diluted in MEM-H with 10% calf serum when used on liv- 
ing cells, or in PBS containing 0.1 M lysine, 0.02% sodium azide, and 10% 
calf serum when used on fixed cells unless otherwise stated. All incubations 
of cultured cells grown on glass coverslips were carried out at room temper- 
ature for 30 rain. Living cells were incubated with 04, galactocerebroside, 
A5E3, 217c, or 192-IgG antibodies followed by G-anti-MIg-Rd or G-anti- 
MIg-FI, or with N-CAM antibodies followed by G-anti-RIg-Rd or G-anti- 
RIg-F1, then permeabilized in 95% ethanol/5% acetic acid for 10 min at 
-20"C. The cells were then incubated in Po antiserum followed by G-anti- 
RIg-F1. In some experiments cells were fixed in 95 % ethanol/5 % acetic acid 
and then incubated in mAbs to Po or GFAP followed by biotinylated sheep 
anti-mouse Ig then streptavidin-Texas  Red. Cells to be labeled with S100 
antibodies were fixed in 4 % paraformaldehyde for 20 rain before permea- 
bilization in 95% ethanol/5% acetic acid for 10 rain at  -20"C. 
The Journal  of Cell Biology,  Volume 112, 1991  458 DNA Replication 
DNA synthesis by Schwann cells was detected by addition of bromodeoxy- 
uridine (BrdU) at a concentration of l0  -5 M  for the final 24 h of culture 
(17). In double-labeling experiments, with Po antibodies cells were washed 
and fixed with 95 % ethanol/5 % acetic acid at -20°C for 10 min. They were 
then treated with 2 N HC1 for about 10 min to denature DNA and 10 min 
with 0.1 M sodium borate (pH 8.5). Coverslips were incubated sequentially 
with anti-BrdU in PBS  containing 0.1%  Triton X-100 for 40 min, with 
G-anti-MIg-Rd, Po antibodies and G-anti-Rig-F1, all for 30 min. In double- 
labeling experiments with 04 antibodies cells were labeled with 04 antibod- 
ies followed by G-anti-MIg-Rd, fixed in 2% paraformaldehyde for l0 min, 
95 % ethanol/5 % acetic acid, 2 N HCI and sodium borate as above, followed 
by anti-BrdU and G-anti-MIg-Rd. There was no difficulty in distinguishing 
04 surface labeling from the nuclear BrdU labeling despite the fact that both 
antibodies were monoclonal since the fixations used after use of the first 
two antibody layers reduced possible cross-reactivity. In some experiments, 
the number of cells per field (using x63 objective) was counted in cultures 
that had been subjected to different experimental treatments resulting in var- 
ious BrdU percentages. It was found that the number of cells per field varied 
proportionally with the number of BrdU positive cells. This indicates that 
the BrdU percentage in these experiments is a measure of proliferation. All 
coverslips were mounted on microscope slides in Citifluor anti-fade mount- 
ing medium (Chemistry Department, City University, London, UK). Im- 
munofluorescence was viewed in a Zeiss microscope using ×40 dry or x63 
oil-immersion phase contrast lenses, epi-illumination and rhodamine or 
fluorescein optics. 
Immunoblotting 
This was carried out using Schwann cells cultured in 75-mm tissue culture 
flasks coated with polylysine and laminin. Initially,  Schwann cells were 
seeded at 5  x  105-106 Schwann cells per dish and treated with doses of 
cAMP analogues, forskolin or CTx for 3 d, as described earlier. Cells were 
cultured in defined medium. Control cultures were maintained without ad- 
dition of analogues. Proteins were extracted from the cells using 0.1 ml of 
2% SDS in 5 mM Tris-Cl, pH 6.8, containing 2 mM EGTA, 2 mM EDTA, 
and 2 mM PMSF per two dishes. The sample was boiled for 5 min, spun 
at 14,000 g for 5 min and 10 pl of supernatant withdrawn for protein deter- 
mination using a protein estimation kit (Bio-Rad Laboratories, Richmond, 
CA). 2 % mercaptoethanol was then added to the supernatant and the ex- 
tracts subjected to SDS-PAGE using a 10-15 % gradient acrylamide slab gel. 
The  separated  proteins  were  then transferred  to  nitrocellulose  and  im- 
munoblotted essentially as described previously (19)  using the Po antise- 
rum at a  concentration of 1:5,000,  and 125I-labeled donkey anti-rabbit Ig 
(ICN Biomedicals Lid., Irvine, CA),  15  x  106 cpm/blot diluted in 20 ml 
of PBS containing 3 % hemoglobin. 
Results 
cAMP Elevation Induces Expression 
of the Myelin Protein Po in Short-Term Cultures 
in Defined Medium 
To avoid the complicating effects of serum, which has been 
included  in  almost  all  previous  studies  on  cAMP  and 
Schwann cell differentiation, we initially studied the effect of 
cAMP elevation on cultured short-term Schwann cells from 
5-d rat sciatic nerve in serum-free, defined medium. Under 
these conditions cAMP does not promote Schwann cell DNA 
synthesis and the proliferation rate is extremely low (see be- 
low). Drug treatment was started after 5 d in vitro. By this 
time the cells had ceased to express immunohistochemically 
detectable levels of myelin proteins and glycolipids, such as 
Po, galactocerebroside, or 04 (22,  29,  32).  We found that 
3 d  after elevation of cAMP by use of CTx,  forskolin or 
cAMP analogues,  expression of the major myelin protein 
Po was clearly seen in the majority of Schwann cells when 
they were examined by immunohistochemical methods using 
Po antibodies.  The Po was also induced, albeit to a lesser 
extent, by IBMX, an inhibitor of phosphodiesterase, as ex- 
Table L Induction of  Po in Defined Medium 
% Po-positive  Sehwann cells 
Treatment  (+  SEM) 
Agents that elevate 
or mimic cAMP 
CTx (150 ng.m1-1)  62  +  6.5  (n  =  14) 
Forskolin (2-4/~M)  37  +  10.7 (n  =  11) 
cAMP analogues  51  +  5.7  (n  =  22) 
IBMX (100/~M)  9  +  3.5  (n  =  8) 
Control  Experiments 
Beta subunit of CTx (150 ng.ml  -~)  0  (n  =  4) 
Ethanol  (0.1% )  0  (n  =  2) 
Butyrate  0.3  +  0.40 (n  =  3) 
GGF (1.8/~g.ml -~)  0.2  +  0.10 (n  =  4) 
Calf serum (10%)  0 (n  =  4) 
0-1  d  in vitro (no additions)  42  +  3.0 (n  =  3) 
5  d  in vitro (no additions)  0  (n  =  1) 
8  d  in vitro (no additions)  0.1  +  0.10 (n  =  10) 
Schwann cells were removed from 5 d rats and cultured for 5 d before addition 
of drugs that elevate cAMP or other agents. The cultures were examined with 
Po antibodies either 3 d after the addition  of drugs, or in control experiments, 
cells were examined after 24 h, 5 d, or 8 d in vitro, without addition of drugs. 
Cyclic AMP analogues, db-cAMP and 8 bromo-cAMP, were used together 
each at a concentration of 5  x  10  -4 M during dl of treatment and at 5  x  10  -5 
M during d2 and d3. Butyrate was used at a total concentration of 5  x  10  -4 
M during dl of treatment and at 5  x  10  -s M during d2 and d3. In each ex- 
periment (n) a minimum of 400 cells were counted, a minimum of 200 cells 
from each of duplicate coverslips.  The number of Po positive cells is ex- 
pressed as a percentage of total Schwann ceils identified  by morphology with 
phase-contrast  illumination  for  the  number  of experiments  indicated.  In 
parallel cultures >95 % of the cells were S100-positive Schwann cells. For data 
on proliferation in CTx, forskolin, and cAMP analogues see Table II. 
pected if expression was  dependent  on  cAMP  elevation. 
These results and results from several control experiments 
are summarized in Table I, and the typical appearance of 
cells induced to express Po is illustrated in Fig.  1. 
Po induction could be detected using either polyclonal or 
monoclonal Po antibodies, although the MAbs generated a 
more speckled and less intense labeling pattern.  The per- 
centage of cells induced to express Po varied quite widely 
from experiment to experiment. The highest percentage seen 
in individual experiments was 84 and 85 % after exposure to 
forskolin and CTx, respectively, whereas the average per- 
centage was considerably lower (Table I). When drugs were 
withdrawn,  Po expression declined to undetectable levels 
(data not shown). 
As  previously reported,  a  characteristic morphological 
change in many of the Schwann cells from a bipolar shape 
to ceils of a  more flattened morphology which were less 
phase bright, was induced by CTx, forskolin, and cAMP an- 
alogues (Fig. 1) (51). The induced cells were notably larger 
in  size and more flattened than cells in the  same culture 
which remained uninduced. This difference in responsive- 
ness of individual cells to elevation of cAMP remains unex- 
plained. 
No  Po  was  seen  in  control  experiments  with  the  beta 
subunit of CTx, ethanol, butyrate, GGF, or calf serum or in 
experiments with serum-free media alone (Table I). 
Po Protein Induced by Elevation of  cAMP Can 
Be Detected in an Immunoblot 
When cells were exposed to agents that elevate cAMP or 
mimic its effect, a clear band of Po protein was  detectable 
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as described  in Materials  and Methods.  (SN) Extract  of 5 d  rat 
sciatic nerve, 25/zg loaded.  Lanes 1-3, extracts from dissociated 
Schwann cell cultures from 5 d rat sciatic nerve treated with agents 
that  elevate or mimic cAMP. Lane 1,  cAMP analogues;  lane 2, 
CTx, lane 3, forskolin, lane 4, no treatment; 31/xg of  extract loaded 
in each lane.  Note that at the Po position,  which is arrowed,  an 
immunoreactive band is visible in the sciatic nerve lane and in each 
of lanes 1-3, but not in lane 4 (control). In the sciatic nerve extract 
a lower breakdown product of Po is also visible. 
Figure 1. Induction of Po in Schwann ceils treated with CTx. Po- 
positive Schwann ceils cultured from 5 d rat sciatic nerve. Ceils 
were cultured on a laminin substrate and treated with CTx as de- 
scribed  in Methods,  and labeled with Po antibodies after 3 d of 
treatment. Cells were viewed with (A) fluorescein optics to visual- 
ize Po, (B) phase-contrast  optics. Note the flattened shape of the 
Schwann cells and the Po immunofluorescence distributed through- 
out the whole area of the cell.  Bar, 20/~M. 
by immunoblotting (Fig.  2).  The extract of freshly excised 
sciatic nerve from a 5-d rat used as a positive control showed 
a  greater intensity of Po protein than the cultured induced 
cells, even though less total protein was loaded on the gel 
track.  On prolonged exposure of the immunoblot to x-ray 
film, a very faint band was also visible in the extract of cells 
cultured for 8 d in the absence of agents which elevate cAMP 
or mimic its effects, even though no label was visible in im- 
munofluorescence experiments (not shown).  This probably 
indicates that cells from 5-d rats, many of which have already 
begun to make myelin, continue to synthesize very low resid- 
ual levels of Po in the absence of axonal contact (39). 
Elevation of  cAMP in Cultured Schwann Cells Mimics 
the Inversion in Protein Expression Characteristic of 
Myelination In Vivo 
When a Schwann cell is induced to form myelin in vivo the 
induction  of myelin  specific proteins,  such  as  Po,  is  fol- 
lowed by down-regulation of a set of proteins that includes 
GFAP, N-CAM, ASE3, and NGFR (21, 23, 26, 27). This in- 
version of protein expression does not occur in non-myelin- 
forming cells,  and  is  reversed on  removal of the  myelin- 
forming cells from axonal contact. Therefore, in the absence 
of drug treatment, essentially all the cells in our cultures ex- 
pressed GFAP, N-CAM, A5E3, and NGFR as reported pre- 
viously  (23),  in  addition  to being Po negative.  We found 
that  elevation  of cAMP  induced  the  myelination-specific 
combination  of protein  up-  and  downregulation  in  many 
cells,  since the expression of GFAP,  N-CAM,  A5E3,  and 
NGFR was strikingly suppressed in a subset of the Po posi- 
tive cells (Figs. 3, 4, and 5). The results obtained using the 
217c antibody to detect the NGFR (15) were confirmed using 
the 192-IgG monoclonal, which also detects the NGFR (53) 
(data not  shown).  The proportion of Po-positive cells that 
assumed this more complete myelin phenotype was larger 
when Po was induced in the presence of serum or GGF al- 
though the total number of Po cells was smaller under those 
conditions  (see below). 
Induction of the Myelin Phenotype and Cell Division 
Are Negatively Correlated 
The ability of cAMP to induce myelin-related differentiation 
under conditions allowing proliferation was compared with 
the induction seen under conditions where DNA synthesis 
did not occur.  The mitogenic response to cAMP elevation 
was regulated in three ways:  (a) by including or excluding 
serum; (b) by including or excluding GGF; (c) by varying 
cell density in the presence of serum. Myelin-related differ- 
entiation was monitored by Po antibodies and immunohisto- 
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N-CAM antibodies (A-C), or mAbs to Po and GFAP antibodies (D-F). Schwann  cells from 5 d sciatic nerve were treated with cAMP 
analogues for 3 d under conditions where both induced and uninduced cells were present in reasonable numbers. Cultures were viewed 
with (A and D) fluorescein optics to visualize Po;  (B and E) rhodamine optics to visualize N-fluorescein optics to visualize Po; (B and 
E); or (C and F) phase-contrast optics. Note that the Po-positive cell seen in A is unlabeled with antibodies to N-CAM (B), while sur- 
rounding Po-negative cells are intensely N-CAM positive, and that the Po-positive cell seen in D  is GFAP negative in E, whereas sur- 
rounding Po-negative cells show typical GFAP immunofluorescence. Note that both the Po-positive cells have assumed a flattened mor- 
phology, seen in C and E  Bar, 20/zM. 
chemistry,  and  DNA  synthesis was assessed by the  BrdU 
method. A negative correlation between induction of the my- 
elin phenotype and cell division was observed in every case. 
The results are summarized in Table II and Fig. 6. 
Serum.  The  ability of cAMP  to  promote Schwann  cell 
growth depends on the simultaneous activation of at least one 
other second messenger pathway by agents such as serum or 
GGE and the mitogenic response to cAMP elevation is low or 
Morgan et al. Induction of Myelin Phenotype  461 Figure 4. Induction of a myelin phenotype in cultured Schwann cells. Double-label immunofluorescence  Using  antibodies to Po and anti- 
bodies to NGFR (detected by the 217c mAb) (A-C); or antibodies to Poand ASE3 antibody (D-F). Schwann cells from 5 d sciatic nerve, 
cultured in high density in serum, were treated with cAMP analogues for 3-d as described in Fig. 3. Cultures were viewed with (.4 and 
D) fluorescein optics to visualize Po; (B and E) rhodamine optics to visualize NGFR (B) or ASE3 antigen (E); or (C and F) phase- 
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and K. R. Jessen, unpublished). We therefore tested the abil- 
ity of cAMP analogues to induce Po expression after 3 d 
and 4 d of exposure to cAMP analogues in the presence of 
0% (defined medium), 0.5 and I0% calf serum (Fig. 6). This 
showed that as the amount of serum was increased, the num- 
ber of Po-positive cells fell very substantially, suggesting a 
strong  negative correlation between proliferation and my- 
elin-related differentiation. Using double label immunofluo- 
rescence we then measured simultaneously the number of 
ceils synthesizing DNA, and the number of cells undergoing 
myelin-related differentiation in cultures under different con- 
ditions. Cultures exposed to cAMP analogues, CTx, or for- 
skolin for 3 d in defined medium on the one hand, and in the 
presence of 10%  calf serum on the other, were compared 
(see Table II, first four columns). The data demonstrate that 
there is a strong inverse relationship between Po expression 
and DNA synthesis. 
Glial Growth Factor. To test alternative means of inducing 
cell division in cultures treated with cAMP elevating agents, 
we used GGF in serum-free defined medium (Stewart, H. J. S., 
R. Mirsky, and K. R. Jessen, unpublished). This greatly in- 
creased DNA synthesis and, as in the case of serum, dramat- 
ically lowered the percentage of cells that are induced to 
make Po (see fifth and sixth columns of Table II). 
Cell Density.  The common action of serum and GGF on 
Schwann cells is to generate conditions under which cAMP 
elevation increases DNA synthesis and the most likely inter- 
pretation of the above results was that a mitogenic response 
involving cAMP was incompatible with myelin-related dif- 
ferentiation. Alternatively, it was possible that serum and 
GGF contained factors that directly blocked induction of the 
myelin phenotype, and that the mitogenic effects of serum 
and GGF were unrelated to the inhibition of myelin-related 
differentiation. To test this we took advantage of  the observa- 
tion that Schwann cells show a strong density-dependent in- 
hibition of  division. Cells were exposed to agents that elevate 
cAMP in the presence of 10% calf serum at low plating den- 
sities, allowing a strong proliferative response, and at a se- 
ries of higher densities when proliferation was increasingly 
suppressed.  Cells  were  plated  at  densities  ranging  from 
2,500 to 20,000 cells per coverslip and exposed to cAMP an- 
alogues for 5 d in in the presence of 10% calf serum. A label- 
ing index of 82 +  4 % was observed at the lowest plating den- 
sity,  and no Po expression was seen. At the highest plating 
density the labeling index observed was 26 +  6.7 and 21  + 
8.5% of the cells expressed Po. Thus, even in the presence 
of serum an inverse relationship between proliferation and 
myelin-related differentiation was revealed. When these data 
(from a total of 28 individual experiments) were analyzed 
using KendaU's rank correlation test, a rank correlation coef- 
ficient, z value of -0.48 (t9 <  0.001) was found, indicating 
a  strong negative correlation between DNA synthesis and 
Po expression. Furthermore, of all the conditions tested in 
the present work, cAMP elevation in high-density cultures 
with 10% calf serum gave the best induction of the myelin 
phenotype in individual cells, i.e., highest levels of Po ex- 
pression as judged by the intensity of immunolabeling, and 
also downregulation of GFAP,  N-CAM, A5E3, and NGFR 
in the largest proportion of the Po-positive cells. Together, 
these observations exclude the possibility that serum con- 
tains factors that directly block cAMP induction of the my- 
elin phenotype, and suggest that serum might in fact contain 
factors that act together with cAMP to promote maximal ex- 
pression of the myelin phenotype, provided DNA synthesis 
is suppressed. 
Individual Cells Expressing Po Do Not Incorporate 
BrrlU and Are Therefore Not Synthesizing DNA 
The results above show that Schwann cell populations re- 
sponded to elevation of cAMP by a high degree of myelin- 
related differentiation and low proliferative activity, or by a 
low level of  differentiation and rapid DNA synthesis depend- 
ing on other conditions in the culture. This suggests that in 
individual Schwann cells cAMP elevation will either stimu- 
late DNA synthesis or induce myelin-related differentiation, 
but not both. To test this, DNA synthesis in the Po-negative 
and -positive Schwann cell populations was compared.  In 
these experirnents plating density was adjusted to obtain sub- 
stantial proportions of both BrdU-positive cells and of Po- 
positive cells in the presence of cAMP analogues and 10% 
calf serum (see previous section). In four experiments the 
number of Po-positive cells averaged 23  +  3.7 %  and the 
number of cells synthesizing DNA within this population 
was only 0.9  +  0.32%, whereas the number of cells syn- 
thesizing DNA within the Po-negative population was 31  + 
3.2%.  This  shows  that cells acquiring the myelin-related 
phenotype and  dividing  cells  are  largely  nonoverlapping 
populations,  suggesting  that  DNA  synthesis  and  myelin- 
related  differentiation are  essentially  incompatible  in  in- 
dividual Schwann cells. 
cAMP Induced 04 Expression Is Not Blocked 
by Proliferation 
In vivo, it is clear that full expression of 04, unlike that of 
Po,  is  compatible  with  proliferation  during  development 
(29). To test whether 04 expression and DNA synthesis were 
compatible in cultured Schwann cells these parameters were 
monitored in cells exposed for 3  d  to 2  /~M forskolin in 
defined medium  and  in  medium  containing GGF.  It was 
found that in defined medium 54  +  8.0%  (n  =  8)  of the 
Schwann cells were 04 positive (BrdU positive cells <5 %), 
while in defined medium with GGF 32 +  12.0% (n =  3) of 
the  cells  expressed 04  (BrdU-positive cells >80%).  This 
reduction in 04  expression is not  statistically  significant. 
Furthermore, in related experiments we found that a large 
proportion of individual cells responded to cAMP elevation 
both by DNA synthesis and 04 expression (Fig. 7). In these 
experiments, cells were exposed to cAMP analogues in the 
presence of 10%  calf serum, resulting in 04 expression in 
88 +  3.7 % (n =  3) of the cells. Of the total cell population 
contrast optics. Note that the Po-positive cell arrowed vertically in (A) is not labeled with NGFR antibodies (B) while surrounding Po- 
negative cells are strongly labeled with NGFR antibody. The Po-positive cell arrowed horizontally in D is likewise very weakly labeled 
with ASE3 antibody, while surrounding Po-negative  cells are strongly A5E3 positive. Note that both Po-positive cells have assumed a fiat- 
tened morphology (C, F). Bar, 20/~M. 
Morgan et al. Induction of Myelin Phenotype  463 Figure 5.  Induction  of a  myelin-related phenotype  in  cultured 
Schwann cells. Double-label immunofluorescence  using antibody to 
NGFR (A) and antibody to GFAP (B). Phase-contrast micrograph 
shown in C.  Culture conditions are as described in Fig. 3. Two 
NGFR negative cells (arrowed)  are surrounded by NGFR-positive 
cells in (A). The same cells are also GFAP negative (arrowed) in 
B, while surrounding cells are GFAP positive. Both of the arrowed 
cells have a typical flattened morphology (C). Bar, 20/~M. 
72  +  8.3% incorporated BrdU, whereas 64 +  6.4% within 
the 04 positive population were also synthesizing DNA. 
The Role of  Laminin 
Laminin-coated substrates were not obligatory for induction 
of the phenotype, since cells cultured on polylysine-coated 
coverslips or tissue culture plastic could be induced to make 
Po in response to elevation of cAMP.  In a representative ex- 
periment, 63 % of cells plated on laminin and 42 % of cells 
plated on polylysine expressed Po after a  3-d exposure to 
cAMP analogues. Extracellular matrix from bovine corneal 
endothelial cells was also effective although in this case the 
cells assumed a process-bearing morphology rather than the 
flattened sheetlike morphology more typical of  cells on lami- 
nin (data not shown). 
Discussion 
We have demonstrated that in short-term Schwann cell cul- 
tures elevation of intracellular cAMP induces expression of 
the major myelin protein Po and,  in the  same  cells,  sup- 
presses expression of a set of proteins all of which are nor- 
mally suppressed during myelination in vivo. We find that 
there is an inverse relationship between induction of the my- 
elin phenotype and DNA synthesis. In contrast, the lipid an- 
tigen 04, which is also induced by cAMP elevation, is readily 
expressed in cells synthesizing DNA. 
The Relationship between cAMP, Proliferation, 
and Differentiation 
An inverse relationship between proliferation and differenti- 
ation  has  not  been  directly  demonstrated  previously  in 
Schwann cells. It is significant that it was observed only with 
respect to myelin-related differentiation. This accords well 
with  in  vivo  development  where  04  appears  at  El6  in 
proliferating cells, but the formation of the first myelin wrap, 
which coincides with the onset of high levels of Po expres- 
sion, is a postmitotic event. Clearly, the effects of cAMP on 
cultured Schwann cells are quite similar to the effects of the 
axon-associated signals  which regulate 04 expression and 
myelination since both induce 04 expression in proliferating 
cells and myelin-related differentiation in quiescent ones. 
The existence of  an axon-associated mitogen has been con- 
vincingly demonstrated in in vitro experiments (46). It is not 
clear to what extent this mitogen drives Schwann cell pro- 
liferation in  embryonic nerves or whether other Schwann 
cell mitogens, also defined in vitro, play a part. These other 
mitogens  include  GGF,  PDGF,  TGF/~, and  FGF  (9,  12- 
14, 47). Agents that elevate cAMP levels synergize with all 
of these polypeptide factors,  possibly via upregulation of 
growth  factor receptors (57).  Furthermore,  in  serum-free 
medium none of these growth factors stimulate Schwann cell 
division except when used with agents that elevate cAMP 
(Stewart,  H.  J.  S.,  R.  Mirsky,  and  K.  R.  Jessen,  unpub- 
lished).  Interestingly,  mitogenic  axonal  membranes  have 
been reported to elevate intracellular cAMP in Schwann cells 
(45), see, however, Meador-Woodruff et al. (28) for a con- 
trary result. 
Together, the present observations and previous work (20, 
22,  32, 50, 51) suggest the possibility that axon-associated 
signals  maintain  elevated cAMP  levels in  Schwann cells, 
The Journal of Cell Biology, Volume 112,  1991  464 Table I1.  The Inverse Relationship between cAMP-mediated Po Induction and DNA Synthesis 
Defined medium  Calf serum (10%)  GGF (1.8/zg.ml  -~) 
% Po-positive  % Schwann cells  % Po-positive  % Schwann cells  % Po-positive  % Schwann cells 
Schwann cells  synthesizing DNA  Schwann cells  synthesizing DNA  Sehwann cells  synthesizing DNA 
Forskolin  37 +  10.7  3 +  2.5  0  90 +  4.3  5 +  4.0  81  +  1.1 
(2-4 ~M)  (n  =  11)  (n  =  5)  (n  =  3)  (n  =  3)  (n  =  3)  (n  =  3) 
cAMP  51  5:5.7  2 +  1.5  1 + 2.1  88 +  3.7  15 + 4.0  72 +  10.2 
analogues  (n  =  22)  (n  =  6)  (n  =  3)  (n  =  3)  (n  =  3)  (n  =  3) 
CTx  62 -t- 6.5  3 +  2.8  0.1  +  0.1  86 +  3.4  4 +  1.5  79 +  8.4 
(n  =  14)  (n  =  4)  (n  =  3)  (n  =  3)  (n  --  3)  (n  =  3) 
For experimental treatment and cell counting procedure see legend to Table I or Materials and Methods. DNA synthesis was assessed by BrdU incorporation and 
immunolabeling and is expressed as percentage of Schwarm cells showing BrdU positive nuclei. In column 1, the data on Po-positive  cells are reproduced from 
Table I for comparison. 
starting from a  relatively early developmental stage (E15- 
El6). In the presence of other mitogenic factors this would 
promote proliferation and trigger 04 expression, but not my- 
elination. Withdrawal from the cell cycle first occurs around 
birth in cells associated with the larger axons via a mecha- 
nism as yet unknown.  In these quiescent cells the ongoing 
cAMP elevation would induce myelination. This implies that 
myelination in vivo may not be triggered directly by a rise 
in cAMP levels, as previously suggested, but by the second- 
ary action of factors that suppress DNA synthesis in cells in 
which cAMP levels have already been elevated. 
Inhibition of Schwann Cell Proliferation 
The mechanisms behind the cessation of proliferation that 
occurs before the  formation of the  first myelin wrap (56) 
could include a lowering of growth factor levels, downregu- 
lation of receptors, the presence of active inhibitory mole- 
cules,  or  contact  inhibition.  Modulation  of the  levels  of 
growth factor receptors on cultured Schwann cells have been 
described but it is not clear whether those observations are 
relevant for growth inhibition  in  vivo (33,  57).  The only 
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Figure 6.  The inverse relationship  between Po induction  and in- 
crease in calf serum. This graph shows that Po is suppressed in the 
presence of increasing concentrations of calf serum. Schwann cells 
were cultured in the presence of cAMP analogues for up to4 d, and 
the percentage of Po positive Schwann cells at each time point as- 
sessed by counting a minimum of 200 cells from each of duplicate 
coverslips. The results from a single representative experiment are 
shown. 
identified protein that actively inhibits Schwann cell DNA 
synthesis in short-term cultured Schwann cells is type 1 col- 
lagen (13),  whereas growth inhibition of these cells is also 
caused by an unidentified factor associated with enteric neu- 
rons (11), and by protein secreted by cultured Schwann cells 
(35). In view of the possibility that cAMP levels in Schwann 
cells in normal nerves are higher than those in cultured cells 
(present paper and references in introduction), it is interest- 
ing  that  provided  cAMP  levels  are  elevated  in  cultured 
Schwann cells, v-interferon acts as a growth inhibitor (14). 
Furthermore, some neurons are known to express interferon- 
like activity (25). 
Effects of  Basal Lamina Components on Induction of 
the Myelin Phenotype 
Studies in vitro have shown that basal lamina formation is 
a prerequisite for myelin formation (6). In our studies exoge- 
nous  laminin did  not  seem to be strictly  required  for in- 
duction of the myelin phenotype since it could be induced on 
a  polylysine substrate.  Laminin is,  however,  produced by 
Schwann  ceils themselves and treatment with cAMP ana- 
logues upregulates expression of laminin in cultured Schwann 
cells (2, 7) so it is difficult to be definitive on this point. The 
strikingly flattened shape of induced cells on laminin does 
suggest that it might play a role in the expansion and flatten- 
ing of the Schwann cell that is required when the Schwann 
cell wraps around the axon and makes myelin in vivo. 
Comparison with Previous Experiments on cAMP 
Induction and Schwann Cell Differentiation 
Our results on induction of the myelin phenotype by eleva- 
tion of intracellular cAMP complement and extend those of 
others. The original experiments of Sobue and Pleasure (50, 
51)  showing  that  galactocerebroside could  be  induced  in 
short-term Schwann cells treated with high doses of cAMP 
analogues or high doses of forskolin suggested a  role for 
cAMP in Schwann cell differentiation.  Shuman et al.  (49) 
reported that another myelin-related protein, PlT0r, could be 
induced in short-term Schwann cell cultures using 8 bromo- 
cAMP (5  x  10  -~ M to 3  x  10  -3 M) or forskolin (100 #M) 
in medium with 10% calf serum. They were, however, un- 
able to  induce  Po under  these  conditions.  In view of the 
results reported in the present paper it seems likely that this 
failure can be traced to a high level of cell division, which 
Morgan et al. Induction of Myelin Phenotype  465 Figure  7.  04 is readily expressed in Schwarm cells  synthesizing 
DNA. Double label immunofluorescence using 04 antibody (A) 
and antibody to BrdU (B). Schwann cells were cultured for 72 h 
in the presence of cAMP analogues. Three 04-positive cells ar- 
rowed in A are also BrdU positive in B, indicating that they can syn- 
thesize DNA. 
was not monitored in these experiments. Using immunoblot- 
ting and Northern blotting techniques, induction of Po and 
Po mRNA by 2/zM forskolin and of myelin basic protein 
mRNA by 20/~M forskolin in the presence of 10% FCS has 
been reported in passaged Schwann cells that have been pre- 
viously exposed to forskolin and GGF for 3--4 wk (24). The 
induction of the POU-domain SCIP gene mRNA before in- 
duction of Po mRNA in the same culture system has been 
recently suggested as an important step in the series of events 
by which elevation of cAMP triggers myelin formation in 
Schwann cells (34). Cell division was not measured in these 
experiments. It should be noted that exposure of long term 
secondary Schwann cellsto mitogenic doses of forskolin and 
GGF leads ultimately to constitutive expression of Po even 
when mitogens are withdrawn (24, 40, 41). Constitutive ex- 
pression of Po has also been reported in long-term Schwann 
cells treated with CTx (54).  Thus regulation of Po may be 
less  stringent  in  long-term  than  in  short-term  cultured 
Schwann cells. 
In  developing nerve,  there are  no biochemical data  on 
cAMP levels. These would, in any case, be difficult to inter- 
pret since cAMP levels in axons, Schwann cells and fibro- 
blastic cells of the endo-, peri-, and epineurium would all 
contribute to the measureit overall level. It has been reported 
that cAMP levels in the adult rabbit sciatic nerve rise sig- 
nificantly in the distal stump of the nerve within 1-6 h after 
crush injury (1) a situation in which cell proliferation is initi- 
ated in previously quiescent Schwann cells, probably in re- 
sponse to macrophage invasion (3,  38). 
Conclusions 
Elevation of cAMP levels mimics events in Schwann cell de- 
velopment that take place in vivo from El6 onwards. These 
include induction of 04 antigen in the presence of DNA syn- 
thesis and induction of the myelin phenotype in quiescent 
cells.  This suggests that in Schwann cells cAMP elevation 
may be a primary developmental signal, with a more general 
action than hitherto envisaged. Neither the present data, nor 
previous work on galactocerebroside and 04 induction, are 
consistent with  the  idea  that  cAMP elevation specifically 
triggers myelination. Rather, we suggest that secondary sig- 
nals removing cells from the cell cycle effectively act as the 
myelination trigger,  since  this  would  permit the  ongoing 
cAMP elevation to induce myelin-specific differentiation. 
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